Benoking 250 mg/125 mg Injection
By Benoking
Rx
1 Injection in a Vial

Composition
Ceftriaxone(250mg) + Sulbactam(125mg)

Manufacturer - Bennet Pharmaceuticals Limited
6th Floor, "B" Wing, Manubhai Towers,Sayajigunj, Vadodara - 390005 Gujarat. India

Expires on or after
September, 2025

liver
When using Benoking 250 mg/125 mg Injection, it is important to be cautious if you have severe liver disease. In such cases, your doctor may need to adjust the dosage of the injection. It is crucial to consult your doctor before using this medication if you have severe liver issues. However, dose adjustment of Benoking 250 mg/125 mg Injection is generally not recommended for patients with mild to moderate liver disease. Always follow your doctor's guidance regarding the proper use of this injection, especially if you have any liver concerns.

kidney
Consult with your doctor for proper guidance before using Benoking 250 mg/125 mg Injection.

alcohol
When taking Benoking 250 mg/125 mg Injection, it is safe to consume alcohol as it does not lead to any harmful effects.

driving
Benoking 250 mg/125 mg Injection can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Benoking 250 mg/125 mg Injection is generally considered safe during pregnancy with low risks based on animal studies. Limited human studies available.

breastfeeding
During breastfeeding, caution is advised when using Benoking 250 mg/125 mg Injection. It is recommended to pause breastfeeding until the treatment of the mother is finished and the drug is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹40
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024